SBIO Holdings Information

SBIO is an equity ETF with a total of 107 individual holdings. The top holdings are Apogee Therapeutics stock at 4.37%, CG Oncology at 3.47%, Xenon Pharmaceuticals at 3.09%, Oruka Therapeutics at 2.97%, and Travere Therapeutics at 2.89%.

Total Holdings

107

Top 10 Percentage

29.68%

Asset Class

Equity

ETF Category

Health

Assets

154.57M

PE Ratio

n/a

Breakdown by Sector

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	APGE	Apogee Therapeutics, Inc.	4.37%	61,993
2	CGON	CG Oncology, Inc.	3.47%	88,463
3	XENE	Xenon Pharmaceuticals Inc.	3.09%	96,782
4	ORKA	Oruka Therapeutics, Inc.	2.97%	60,497
5	TVTX	Travere Therapeutics, Inc.	2.89%	93,184
6	DNTH	Dianthus Therapeutics, Inc.	2.79%	54,813
7	MANE	Veradermics, Incorporated	2.75%	41,848
8	DFTX	Definium Therapeutics, Inc.	2.71%	109,454
9	EWTX	Edgewise Therapeutics, Inc.	2.35%	107,873
10	ACAD	ACADIA Pharmaceuticals Inc.	2.29%	171,325
11	RLAY	Relay Therapeutics, Inc.	2.29%	218,519
12	DNLI	Denali Therapeutics Inc.	2.19%	159,019
13	NAMS	NewAmsterdam Pharma Company N.V.	2.11%	117,144
14	CRNX	Crinetics Pharmaceuticals, Inc.	2.07%	105,506
15	GPCR	Structure Therapeutics Inc.	1.96%	71,224
16	DYN	Dyne Therapeutics, Inc.	1.87%	165,666
17	IDYA	IDEAYA Biosciences, Inc.	1.71%	88,016
18	VERA	Vera Therapeutics, Inc.	1.65%	71,942
19	CLDX	Celldex Therapeutics, Inc.	1.56%	78,493
20	SLS	SELLAS Life Sciences Group, Inc.	1.53%	186,514
21	IRON	Disc Medicine, Inc.	1.51%	38,238
22	KLRA	Kailera Therapeutics, Inc.	1.50%	129,890
23	TARS	Tarsus Pharmaceuticals, Inc.	1.40%	42,996
24	MBX	MBX Biosciences, Inc.	1.36%	47,604
25	BCRX	BioCryst Pharmaceuticals, Inc.	1.29%	254,777

Showing 25 of 107 holdings

Subscribe to see the full list

Activate Now

As of Jun 29, 2026